MSFP
ANIP icon

Mark Sheptoff Financial Planning’s ANI Pharmaceuticals ANIP Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,450
Closed -$251K – 360
2019
Q3 		$251K Sell
3,450
-300
-8% -$22.4K 0.17% 84
2019
Q2 		$308K Hold
3,750
– – 0.21% 75
2019
Q1 		$265K Hold
3,750
– – 0.19% 79
2018
Q4 		$169K Sell
3,750
-300
-7% -$15.7K 0.14% 86
2018
Q3 		$229K Hold
4,050
– – 0.16% 94
2018
Q2 		$271K Hold
4,050
– – 0.2% 88
2018
Q1 		$236K Hold
4,050
– – 0.16% 92
2017
Q4 		$261K Sell
4,050
-1,200
-23% -$74.7K 0.17% 94
2017
Q3 		$276K Sell
5,250
-300
-5% -$14.3K 0.19% 97
2017
Q2 		$260K Buy
5,550
+500
+10% +$24.1K 0.18% 95
2017
Q1 		$250K Buy
5,050
+1,200
+31% +$67.4K 0.18% 90
2016
Q4 		$233K Sell
3,850
-100
-3% -$6.12K 0.17% 90
2016
Q3 		$262K Hold
3,950
– – 0.19% 83
2016
Q2 		$220K Hold
3,950
– – 0.16% 86
2016
Q1 		$133K Sell
3,950
-300
-7% -$10.2K 0.11% 107
2015
Q4 		$192K Buy
4,250
+1,150
+37% +$49.5K 0.16% 92
2015
Q3 		$122K Buy
3,100
+400
+15% +$22.8K 0.11% 122
2015
Q2 		$168K Buy
2,700
+600
+29% +$35.7K 0.14% 111
2015
Q1 		$131K Hold
2,100
– – 0.11% 126
2014
Q4 		$118K Buy
+2,100
New +$92.6K 0.1% 125

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Mark Sheptoff Financial Planning's ANIP Position: Q4 2019 in Review

Mark Sheptoff Financial Planning sold out of ANI Pharmaceuticals (ANIP) in Q4 2019, closing a stake of 3,450 shares — an estimated $251K sold.

Mark Sheptoff Financial Planning first reported a position in ANIP in Q4 2014 and held it in 20 quarters. The position peaked at $308K in Q2 2019. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2019.

  • Mark Sheptoff Financial Planning reported no remaining ANI Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 3,450 ANI Pharmaceuticals shares in Q4 2019, an estimated $251K.
  • Mark Sheptoff Financial Planning first reported a position in ANI Pharmaceuticals in Q4 2014 and held it in 20 quarters.
  • Mark Sheptoff Financial Planning's ANI Pharmaceuticals position peaked at $308K in Q2 2019.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2019.

Based on Mark Sheptoff Financial Planning's 13F filing for Q4 2019, filed 10 Feb 2020.